Unbiased AI-powered news
The Bureau of Labor Statistics reported an 8.3 percent unemployment rate for Generation Z, double the national average of 4.2 percent. Career coaches and recruiters described strategies for handling repeated rejections during extended job searches.
NewsweekU.S. 2 percent. More than 163 million Americans remain employed while millions of others submit repeated applications through automated systems that often yield no response.
Eva Chan, career expert at Resume Genius, said the main stressors are rejections, lack of employer responses, financial pressure, and difficulty staying motivated. She recommended maintaining a proof file of past achievements and positive feedback to counter negative self-perception during interviews.
Margaret Buj, a recruiter, advised following up once or twice after seven to ten business days and then archiving unresponsive applications. She stated that silence from employers creates false hope and that candidates should limit emotional investment after the follow-up period.
Tara Kermiet, a burnout and career coach, described focusing effort on controllable factors such as how experience is presented and which roles are targeted. She recommended treating the search as a scheduled work block with defined start and end times.
Dante Rosh, a career and leadership coach, said applicants should send a solid application, conduct some networking, and then move on to other opportunities. He added that rejection should be treated as data rather than a measure of personal worth.
Single source — no framing comparison available.
A 26-year-old Colombian national was fatally shot in Biddeford on Monday. The incident prompted federal officials to suspend most vehicle stops nationwide after two recent deaths.
Al JazeeraSix officers were buried at al-Shifa Hospital in Gaza City on July 14. The death toll since the October ceasefire reached 1,108, with cumulative figures since 2023 at 73,231 killed.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.